查看购物车
  • Traditional Chinese
  • English
  • Japanese
2021-2031 年北美抗菌手术缝线市场报告（范围、细分、动态和竞争分析）
市场调查报告书
商品编码
1784612

2021-2031 年北美抗菌手术缝线市场报告（范围、细分、动态和竞争分析）

North America Antimicrobial Surgical Suture Market Report 2021-2031 by Scope, Segmentation, Dynamics, and Competitive Analysis
出版日期: | 出版商: The Insight Partners | 英文 111 Pages | 订单完成后即时交付

价格

北美抗菌手术缝线市场规模预计将从 2023 年的 1.5964 亿美元增至 2031 年的 3.2952 亿美元。预计 2024 年至 2031 年期间该市场的复合年增长率为 9.6%。

执行摘要和北美抗菌手术缝合线市场分析：

北美抗菌手术缝线市场分为美国、加拿大和墨西哥。 2023年，美国占了最大的市场份额。随着骨科手术、整形手术、心血管手术和剖腹产手术的增多，市场参与者对抗菌手术缝合线生产的关注度不断提高，这推动了抗菌手术缝合线市场的发展。

北美抗菌手术缝合线市场細項分析：

有助于得出抗菌手术缝线市场分析的关键部分是类型、原材料、应用和最终用户。

根据类型，北美抗菌手术缝线市场细分为三氯生抗菌缝线和氯己定抗菌缝线。 2023年，三氯生抗菌缝线占据了较大的市场份额。

根据原料，北美抗菌手术缝线市场细分为聚乳酸910抗菌缝线、聚卡普隆25和聚乙醇酸。聚乳酸910抗菌缝合线在2023年占据了最大的市场份额。

根据应用，北美抗菌手术缝线市场细分为心血管外科、一般外科、眼科外科、妇科外科、骨科外科、整形外科、兽医外科、牙科外科等。心血管外科在2023年占据了最大的市场。

按最终用户划分，北美抗菌手术缝合线市场分为医院、门诊手术中心和其他。 2023年，医院占据了最大的市场。

北美抗菌手术缝合线市场展望

根据美国外科医师学会的数据，全球约有1-2%的人一生中可能会经历一次慢性伤口。同样，根据美国疾病管制与预防中心 (CDC) 的估计，美国医护人员每年约有38.5万起锐器伤，而这个数字很可能在一年内达到80万起。除了锐器伤之外，全球其他类型的工作场所或职业伤害数量也在增加。根据国际劳工组织的数据，每年约有230万人遭受工伤，影响他们的健康和生活品质。慢性伤口负担的不断增加最终推动了对先进伤口护理管理方法的需求，以大幅减轻国家医疗系统的财务负担。各国在治疗伤口和避免相关风险方面投入了大量资金。例如，在美国，医疗保健系统每年在治疗伤口及其相关併发症方面的支出超过250亿美元。因此，随着慢性伤口发生率的上升，全球对抗菌手术缝线的需求也不断增加。

此外，全球医疗机构进行的普通手术、心血管手术、骨科手术、妇科手术和癌症手术数量正在大幅增加。根据 Atrial Health 在 2023 年发布的资料，美国每年进行约 30 万例心臟手术。此外，老年人口的增长导致了一些严重的健康问题（例如疝气和白内障），这些问题需要手术作为主要治疗选择。老年人口容易罹患心血管疾病、骨科疾病、代谢性疾病和神经系统疾病等。据世界卫生组织称，全球老龄人口可能会从 2019 年的约 10 亿增加到 2050 年的约 21 亿。美容手术在娱乐业的从业者中也变得很普遍。这些手术适用于患有意外或先天畸形的患者以及希望让自己的外表更有吸引力的患者。因此，医院或类似医疗机构进行的手术数量激增，推动了对抗菌手术缝合线的需求。

北美抗菌手术缝合线市场国家洞察

按国家划分，北美抗菌手术缝线市场包括美国、加拿大和墨西哥。美国在2023年占最大份额。

由于烘焙食品和糖果产量的增加，美国抗菌手术缝合线市场预计将蓬勃发展。美国外科手术数量的增加以及美容整形手术支出的增加，正在推动市场的成长。根据美国整形外科医师协会的数据，2018年，美国在美容整形手术上的支出达165亿美元。美国山区/太平洋地区以美容整形手术闻名。美国已实施超过150万例外科美容手术和超过550万例非外科手术。

心血管疾病 (CVD) 和中风给美国带来了巨大的健康负担。根据美国心臟学会的报告，美国约有 80 万人死于心血管疾病。冠心病是死亡的主要原因，其次是中风和心臟衰竭。然而，由于人们对先进医疗诊断、治疗、医疗保险和报销的认识不断提高，过去十年因冠心病死亡的人数有所下降。因此，医疗疗法的兴起带动了心血管、骨科和美容手术的增加。这反过来又将刺激对抗菌手术缝合线的需求。

北美抗菌手术缝合线市场公司简介

市场上的一些主要参与者包括 Advanced MedTech Solutions Pvt. Ltd.、Cencora, Inc.（AmerisourceBergen Corporation）、Healthium Medtech Limited、Internacional Farmaceutica SA、强生公司、Meril Life Sciences Pvt Ltd、TI Medical 和 Unilene 等。这些参与者正在采取各种策略，例如扩张、产品创新和併购，以向消费者提供创新产品并增加市场份额。

北美抗菌手术缝合线市场研究方法：

本报告中的资料收集和分析遵循了以下方法：

二手资料研究：研究流程始于全面的二手资料研究，利用内部和外部资源收集每个市场的定性和定量资料。常用的二手资料研究来源包括但不限于：

公司网站、年度报告、财务报表、经纪商分析和投资者介绍。行业期刊及其他相关出版品。政府文件、统计资料库和市场报告。针对在市场运营的公司的新闻文章、新闻稿和网路广播。註：公司简介部分所包含的所有财务资料均已标准化为美元。对于以其他货币报告的公司，数据已使用相应年份的相关汇率转换为美元。

一手研究 Insight Partners 每年都会与行业利益相关者和专家进行大量的一手调查，以验证其资料分析，并获得宝贵的见解。这些研究访谈旨在：

验证并完善二手资料研究的结果。提升分析团队的专业知识和市场理解。深入了解市场规模、趋势、成长模式、竞争动态和未来前景。一手资料研究透过电子邮件互动和电话访谈进行，涵盖不同地区的各种市场、类别、细分市场和次细分市场。参与者通常包括：

产业利害关係人：副总裁、业务发展经理、市场情报经理和国家销售经理外部专家：估值专家、研究分析师和具有行业专业知识的关键意见领袖

目录

第一章：简介

第二章：执行摘要

  • 关键见解

第三章：研究方法

  • 二次研究
  • 初步研究
    • 假设表述：
    • 宏观经济因素分析：
    • 显影基数：
    • 数据三角测量：
    • 国家级资料：

第四章：北美抗菌手术缝线市场格局

  • PEST分析

第五章：北美抗菌手术缝合线市场-关键市场动态

  • 市场驱动因素：
    • 手术部位感染盛行率激增
    • 慢性伤口和手术病例增加
  • 市场限制
    • 非侵入性缝合替代品
  • 市场机会
    • 抗菌外科缝合线的策略性倡议
  • 未来趋势
    • 智慧抗菌缝合线
  • 驱动因素和限制因素的影响：

第六章：抗菌手术缝合线市场－北美分析

  • 2021-2031年北美抗菌手术缝线市场收入
  • 北美抗菌手术缝合线市场预测分析

第七章：北美抗菌手术缝合线市场分析-按类型

  • 三氯生抗菌缝合线
  • 氯己定抗菌缝合线

第八章：北美抗菌手术缝合线市场分析-依原料

  • Polyglactin 910抗菌缝线
  • 聚卡普隆 25
  • 聚乙醇酸

第九章：北美抗菌手术缝合线市场分析-按应用

  • 心血管外科
  • 一般外科
  • 眼科手术
  • 妇科手术
  • 骨科手术
  • 整型手术
  • 兽医外科
  • 牙科手术
  • 其他的

第 10 章：北美抗菌手术缝线市场分析 - 按最终用户

  • 医院
  • 门诊手术中心
  • 其他的

第 11 章：北美抗菌手术缝线市场 - 国家分析

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥

第 12 章：产业格局

  • 概述
  • 成长策略
    • 概述
  • 2023年公司市占率分析（%）

第十三章：公司简介

  • TI Medical
  • Healthium Medtech Limited
  • Meril Life Sciences Pvt Ltd
  • Unilene
  • Johnson & Johnson
  • Cencora, Inc. (AmerisourceBergen Corporation)
  • Advanced MedTech Solutions Pvt. Ltd.
  • Internacional Farmaceutica SA

第 14 章：附录

Product Code: BMIRE00031797

The North America antimicrobial surgical suture market size is expected to reach US$ 329.52 million by 2031 from US$ 159.64 million in 2023. The market is estimated to record a CAGR of 9.6% from 2024-2031.

Executive Summary and North America Antimicrobial Surgical Suture Market Analysis:

The North America antimicrobial surgical sutures market is segmented into the US, Canada, and Mexico. In 2023, the US held the largest share of the market. The increasing focus of market players on manufacturing antimicrobial surgical sutures due to the rise in orthopedic surgeries, plastic surgeries, cardiovascular surgeries, and C-section deliveries drives the antimicrobial surgical sutures market.

North America Antimicrobial Surgical Suture Market Segmentation Analysis:

Key segments that contributed to the derivation of the antimicrobial surgical suture market analysis are type, raw materials, application, and end user.

Based on type, the North America antimicrobial surgical suture market is sub segmented into triclosan antimicrobial suture and chlorhexidine antimicrobial suture. The triclosan antimicrobial suture held a larger share of the market in 2023.

By raw materials, the North America antimicrobial surgical suture market is segmented into polyglactin 910 antimicrobial suture, poliglecaprone 25, and polyglycolic acid. The polyglactin 910 antimicrobial suture segment held the largest share of the market in 2023.

By application, the North America antimicrobial surgical suture market is segmented into cardiovascular surgery, general surgery, ophthalmic surgery, gynecological surgery, orthopedic surgery, plastic surgery, veterinary surgery, dental surgery, and others. The cardiovascular surgery segment held the largest share of the market in 2023.

By end user, the North America antimicrobial surgical suture market is segmented into hospitals, ambulatory surgical centers, and others. The hospitals segment held the largest share of the market in 2023.

North America Antimicrobial Surgical Suture Market Outlook

According to the American College of Surgeons, ~1-2% of individuals in the world are likely to experience chronic wounds once in their lifetime. Similarly, as per the estimates from the Centers for Disease Control and Prevention (CDC), ~385,000 sharps injuries occur among healthcare workers in the US every year, and the number is likely to reach up to 800,000 injuries within one year. Besides sharp injuries, the number of other types of workplace or occupational injuries is increasing worldwide. According to the International Labor Organization, ~2.3 million people experience work-related injuries every year, affecting their health and quality of life. The soaring burden of chronic wounds eventually propels the demand for advanced wound care management methods to substantially reduce the financial burden from national healthcare systems. Various countries spend significant amounts of money on treating injuries and avoiding associated risks. For instance, in the US, the healthcare system spends over US$ 25 billion on treating wounds and related complications every year. Therefore, with the increasing incidence of chronic wounds, the demand for antimicrobial surgical sutures is also increasing worldwide.

Further, the number of general, cardiovascular, orthopedic, gynecological, and cancer surgeries performed in healthcare settings is increasing tremendously across the world. According to the data published by Atrial Health in 2023, ~300,000 cardiac surgeries are performed in the US every year. Moreover, the growing geriatric population contributes to severe health conditions (e.g., hernia and cataracts) that require surgeries as a primary treatment option. The geriatric population is prone to CVDs, orthopedic disorders, metabolic disorders, and neurological disorders, among others. According to the WHO, the aging population across the world is likely to rise from ~1 billion in 2019 to ~2.1 billion by 2050. Aesthetic surgeries have also become common among people working in the entertainment industry. These surgeries are performed on patients who have accidental or inherent deformities and on those who wish to make their appearance more appealing. Therefore, the surging number of surgeries performed in hospitals or similar healthcare institutions is driving the demand for antimicrobial surgical sutures.

North America Antimicrobial Surgical Suture Market Country Insights

Based on country, the North America antimicrobial surgical suture market comprises the US, Canada, and Mexico. The US held the largest share in 2023.

The US antimicrobial surgical suture market is expected to proliferate owing to the increased production of bakery and confectionery The increasing surgical procedure and the rising spending on cosmetic or plastic surgeries in the US are propelling the market growth. As per the American Society of Plastic Surgeons, in 2018, US$ 16.5 Billion was spent on cosmetic procedures in the US. The Mountain/Pacific region in the US is more famous for cosmetic surgeries. More than 1,500,000 surgical cosmetic operations and more than 5,500,000 nonsurgical procedures were carried out in the US.

Cardiovascular diseases (CVDs) and stroke produce immense health burdens in the US. According to the American College of Cardiology's reports, ~800,000 deaths were noted in the United States. The primary cause of death is coronary heart disease, followed by heart stroke and heart failure. However, deaths due to coronary heart disease have declined over the past decade due to the awareness of advanced medical diagnosis, treatments, medical insurance, and reimbursements. Therefore, the rise in medical therapies has led to an increase in cardiovascular, orthopedics, and cosmetic surgeries. This, in turn, will fuel the need for antimicrobial surgical sutures.

North America Antimicrobial Surgical Suture Market Company Profiles

Some of the key players operating in the market include Advanced MedTech Solutions Pvt. Ltd.; Cencora, Inc. (AmerisourceBergen Corporation); Healthium Medtech Limited; Internacional Farmaceutica SA; Johnson & Johnson; Meril Life Sciences Pvt Ltd; TI Medical; and Unilene among others. These players are adopting various strategies such as expansion, product innovation, and mergers and acquisitions to provide innovative products to their consumers and increase their market share.

North America Antimicrobial Surgical Suture Market Research Methodology :

The following methodology has been followed for the collection and analysis of data presented in this report:

Secondary Research The research process begins with comprehensive secondary research, utilizing both internal and external sources to gather qualitative and quantitative data for each market. Commonly referenced secondary research sources include, but are not limited to:

Company websites , annual reports, financial statements, broker analyses, and investor presentations. Industry trade journals and other relevant publications. Government documents , statistical databases, and market reports. News articles , press releases, and webcasts specific to companies operating in the market. Note: All financial data included in the Company Profiles section has been standardized to USD. For companies reporting in other currencies, figures have been converted to USD using the relevant exchange rates for the corresponding year.

Primary Research The Insight Partners' conducts a significant number of primary interviews each year with industry stakeholders and experts to validate its data analysis, and gain valuable insights. These research interviews are designed to:

Validate and refine findings from secondary research. Enhance the expertise and market understanding of the analysis team. Gain insights into market size, trends, growth patterns, competitive dynamics, and future prospects. Primary research is conducted via email interactions and telephone interviews, encompassing various markets, categories, segments, and sub-segments across different regions. Participants typically include:

Industry stakeholders : Vice Presidents, business development managers, market intelligence managers, and national sales managers External experts : Valuation specialists, research analysts, and key opinion leaders with industry-specific expertise

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Secondary Research
  • 3.2 Primary Research
    • 3.2.1 Hypothesis formulation:
    • 3.2.2 Macro-economic factor analysis:
    • 3.2.3 Developing base number:
    • 3.2.4 Data Triangulation:
    • 3.2.5 Country level data:

4. North America Antimicrobial Surgical Suture Market Landscape

  • 4.1 PEST Analysis

5. North America Antimicrobial Surgical Suture Market - Key Market Dynamics

  • 5.1 Market Drivers:
    • 5.1.1 Surging Prevalence of Surgical Site Infections
    • 5.1.2 Increasing Cases of Chronic Wounds and Surgeries
  • 5.2 Market Restraints
    • 5.2.1 Non-invasive Alternatives to Stitches
  • 5.3 Market Opportunities
    • 5.3.1 Strategic Initiatives in Antimicrobial Surgical Suture
  • 5.4 Future Trends
    • 5.4.1 Smart Antimicrobial Sutures
  • 5.5 Impact of Drivers and Restraints:

6. Antimicrobial Surgical Suture Market - North America Analysis

  • 6.1 North America Antimicrobial Surgical Suture Market Revenue (US$ Million), 2021-2031
  • 6.2 North America Antimicrobial Surgical Suture Market Forecast Analysis

7. North America Antimicrobial Surgical Suture Market Analysis - by Type

  • 7.1 Triclosan Antimicrobial Suture
    • 7.1.1 Overview
    • 7.1.2 Triclosan Antimicrobial Suture: North America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.2 Chlorhexidine Antimicrobial Suture
    • 7.2.1 Overview
    • 7.2.2 Chlorhexidine Antimicrobial Suture: North America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)

8. North America Antimicrobial Surgical Suture Market Analysis - by Raw Materials

  • 8.1 Polyglactin 910 Antimicrobial Suture
    • 8.1.1 Overview
    • 8.1.2 Polyglactin 910 Antimicrobial Suture: North America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.2 Poliglecaprone 25
    • 8.2.1 Overview
    • 8.2.2 Poliglecaprone 25: North America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.3 Polyglycolic Acid
    • 8.3.1 Overview
    • 8.3.2 Polyglycolic Acid: North America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)

9. North America Antimicrobial Surgical Suture Market Analysis - by Application

  • 9.1 Cardiovascular Surgery
    • 9.1.1 Overview
    • 9.1.2 Cardiovascular Surgery: North America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.2 General Surgery
    • 9.2.1 Overview
    • 9.2.2 General Surgery: North America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.3 Ophthalmic Surgery
    • 9.3.1 Overview
    • 9.3.2 Ophthalmic Surgery: North America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.4 Gynaecological Surgery
    • 9.4.1 Overview
    • 9.4.2 Gynaecological Surgery: North America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.5 Orthopedic Surgery
    • 9.5.1 Overview
    • 9.5.2 Orthopedic Surgery: North America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.6 Plastic Surgery
    • 9.6.1 Overview
    • 9.6.2 Plastic Surgery: North America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.7 Veterinary Surgery
    • 9.7.1 Overview
    • 9.7.2 Veterinary Surgery: North America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.8 Dental Surgery
    • 9.8.1 Overview
    • 9.8.2 Dental Surgery: North America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.9 Others
    • 9.9.1 Overview
    • 9.9.2 Others: North America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)

10. North America Antimicrobial Surgical Suture Market Analysis - by End User

  • 10.1 Hospitals
    • 10.1.1 Overview
    • 10.1.2 Hospitals: North America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
  • 10.2 Ambulatory Surgical Centers
    • 10.2.1 Overview
    • 10.2.2 Ambulatory Surgical Centers: North America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
  • 10.3 Others
    • 10.3.1 Overview
    • 10.3.2 Others: North America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)

11. North America Antimicrobial Surgical Suture Market - Country Analysis

  • 11.1 North America
    • 11.1.1 North America Antimicrobial Surgical Suture Market Overview
    • 11.1.2 North America Antimicrobial Surgical Suture Market - Breakdown, by Key Countries, 2023 and 2031 (%)
      • 11.1.2.1 United States: North America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
        • 11.1.2.1.1 United States: North America Antimicrobial Surgical Suture Market Breakdown, by Type
        • 11.1.2.1.2 United States: North America Antimicrobial Surgical Suture Market Breakdown, by Raw Materials
        • 11.1.2.1.3 United States: North America Antimicrobial Surgical Suture Market Breakdown, by Application
        • 11.1.2.1.4 United States: North America Antimicrobial Surgical Suture Market Breakdown, by End User
      • 11.1.2.2 Canada: North America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
        • 11.1.2.2.1 Canada: North America Antimicrobial Surgical Suture Market Breakdown, by Type
        • 11.1.2.2.2 Canada: North America Antimicrobial Surgical Suture Market Breakdown, by Raw Materials
        • 11.1.2.2.3 Canada: North America Antimicrobial Surgical Suture Market Breakdown, by Application
        • 11.1.2.2.4 Canada: North America Antimicrobial Surgical Suture Market Breakdown, by End User
      • 11.1.2.3 Mexico: North America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
        • 11.1.2.3.1 Mexico: North America Antimicrobial Surgical Suture Market Breakdown, by Type
        • 11.1.2.3.2 Mexico: North America Antimicrobial Surgical Suture Market Breakdown, by Raw Materials
        • 11.1.2.3.3 Mexico: North America Antimicrobial Surgical Suture Market Breakdown, by Application
        • 11.1.2.3.4 Mexico: North America Antimicrobial Surgical Suture Market Breakdown, by End User

12. Industry Landscape

  • 12.1 Overview
  • 12.2 Growth Strategies
    • 12.2.1 Overview
  • 12.3 Company Market Share Analysis (%), 2023

13. Company Profiles

  • 13.1 TI Medical
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 Healthium Medtech Limited
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Products and Services
    • 13.2.4 Financial Overview
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 Meril Life Sciences Pvt Ltd
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Products and Services
    • 13.3.4 Financial Overview
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 Unilene
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Products and Services
    • 13.4.4 Financial Overview
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 Johnson & Johnson
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Products and Services
    • 13.5.4 Financial Overview
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.6 Cencora, Inc. (AmerisourceBergen Corporation)
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Products and Services
    • 13.6.4 Financial Overview
    • 13.6.5 SWOT Analysis
    • 13.6.6 Key Developments
  • 13.7 Advanced MedTech Solutions Pvt. Ltd.
    • 13.7.1 Key Facts
    • 13.7.2 Business Description
    • 13.7.3 Products and Services
    • 13.7.4 Financial Overview
    • 13.7.5 SWOT Analysis
    • 13.7.6 Key Developments
  • 13.8 Internacional Farmaceutica SA
    • 13.8.1 Key Facts
    • 13.8.2 Business Description
    • 13.8.3 Products and Services
    • 13.8.4 Financial Overview
    • 13.8.5 SWOT Analysis
    • 13.8.6 Key Developments

14. Appendix

  • 14.1 About The Insight Partners
  • 14.2 Glossary of Terms

List Of Tables

  • Table 1. North America Antimicrobial Surgical Suture Market Segmentation
  • Table 2. North America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
  • Table 3. United States: North America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 4. United States: North America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031(US$ Million) - by Raw Materials
  • Table 5. United States: North America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 6. United States: North America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 7. Canada: North America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 8. Canada: North America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031(US$ Million) - by Raw Materials
  • Table 9. Canada: North America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 10. Canada: North America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 11. Mexico: North America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 12. Mexico: North America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031(US$ Million) - by Raw Materials
  • Table 13. Mexico: North America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 14. Mexico: North America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 15. Recent Growth Strategies in North America Antimicrobial Surgical Suture Market
  • Table 16. Glossary of Terms, Antimicrobial Surgical Suture Market

List Of Figures

  • Figure 1. North America Antimicrobial Surgical Suture Market Segmentation, by Country
  • Figure 2. PEST Analysis
  • Figure 3. North America Antimicrobial Surgical Suture Market - Key Market Dynamics
  • Figure 4. Impact Analysis of Drivers and Restraints
  • Figure 5. North America Antimicrobial Surgical Suture Market Revenue (US$ Million), 2021-2031
  • Figure 6. North America Antimicrobial Surgical Suture Market Share (%) - by Type (2023 and 2031)
  • Figure 7. Triclosan Antimicrobial Suture: North America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 8. Chlorhexidine Antimicrobial Suture: North America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 9. North America Antimicrobial Surgical Suture Market Share (%) - by Raw Materials (2023 and 2031)
  • Figure 10. Polyglactin 910 Antimicrobial Suture: North America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 11. Poliglecaprone 25: North America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 12. Polyglycolic Acid: North America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 13. North America Antimicrobial Surgical Suture Market Share (%) - by Application (2023 and 2031)
  • Figure 14. Cardiovascular Surgery: North America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 15. General Surgery: North America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 16. Ophthalmic Surgery: North America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 17. Gynaecological Surgery: North America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 18. Orthopedic Surgery: North America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 19. Plastic Surgery: North America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 20. Veterinary Surgery: North America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 21. Dental Surgery: North America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 22. Others: North America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 23. North America Antimicrobial Surgical Suture Market Share (%) - by End User (2023 and 2031)
  • Figure 24. Hospitals: North America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 25. Ambulatory Surgical Centers: North America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 26. Others: North America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 27. North America Antimicrobial Surgical Suture Market Breakdown, by Key Countries - Revenue (2023) (US$ Million)
  • Figure 28. North America Antimicrobial Surgical Suture Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 29. United States: North America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 30. Canada: North America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 31. Mexico: North America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031(US$ Million)